Increase in services provided in 2023 by all sequencing platforms, excluding COVID-related activities Positive EBITDA for the third year running, despite inflation impacting reagent costs SeqOIA...
Significant reduction of COVID-19 related activities Growth of all other lines of business Cash totaling €2.9m on Dec 31st, 2023 Laboratory in Évry accredited by the College of American...
Résilience de la rentabilité malgré le contexte inflationniste Croissance des activités aux laboratoires d’Évry Regulatory News: IntegraGen (FR0010908723 – ALINT – Eligible PEA PME...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.01 | 1.81818181818 | 0.55 | 0.59 | 0.55 | 471 | 0.56532512 | DE |
4 | -0.075 | -11.811023622 | 0.635 | 0.635 | 0.53 | 744 | 0.57949802 | DE |
12 | -0.1 | -15.1515151515 | 0.66 | 0.84 | 0.53 | 5345 | 0.66889551 | DE |
26 | -0.292 | -34.2723004695 | 0.852 | 0.93 | 0.53 | 5403 | 0.72799436 | DE |
52 | -0.89 | -61.3793103448 | 1.45 | 1.5 | 0.53 | 4025 | 0.86609364 | DE |
156 | -0.9 | -61.6438356164 | 1.46 | 2.04 | 0.53 | 5012 | 1.23559867 | DE |
260 | -0.69 | -55.2 | 1.25 | 2.67 | 0.53 | 34369 | 1.67215502 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.